Bioqual, Inc. (BIOQ)
OTCMKTS · Delayed Price · Currency is USD
33.00
0.00 (0.00%)
At close: Aug 31, 2026
Bioqual Ratios and Metrics
Market cap in millions USD. Fiscal year is June - May.
Millions USD. Fiscal year is Jun - May.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 |
| 30 | 40 | 65 | 68 | 63 | 73 | |
Market Cap Growth | -23.59% | -37.93% | -4.61% | 8.57% | -13.69% | 35.17% |
Enterprise Value | 50 | 46 | 71 | 83 | 80 | 83 |
Last Close Price | 33.00 | 45.00 | 71.96 | 74.81 | 68.01 | 77.63 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 |
PE Ratio | - | - | 134.12 | 81.36 | 11.90 | 11.47 |
PS Ratio | 0.70 | 0.82 | 1.11 | 1.09 | 0.95 | 1.26 |
PB Ratio | 0.84 | 1.11 | 1.72 | 1.81 | 1.66 | 2.16 |
P/TBV Ratio | 0.87 | 1.15 | 1.77 | 1.86 | 1.71 | 2.23 |
P/FCF Ratio | 4.97 | 14.87 | 7.40 | 11.35 | - | - |
P/OCF Ratio | 4.70 | 13.67 | 6.93 | 8.26 | 199.80 | 33.89 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 |
EV/Sales Ratio | 1.17 | 0.94 | 1.22 | 1.33 | 1.21 | 1.44 |
EV/EBITDA Ratio | 9.37 | 97.11 | 28.17 | 24.59 | 9.68 | 8.35 |
EV/EBIT Ratio | - | - | - | 75.35 | 12.21 | 9.68 |
EV/FCF Ratio | 8.37 | 17.01 | 8.15 | 13.88 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 |
Debt / Equity Ratio | 0.96 | 0.46 | 0.39 | 0.50 | 0.50 | 0.44 |
Debt / EBITDA Ratio | 6.31 | 3.19 | 2.07 | 2.54 | 1.54 | 1.06 |
Debt / FCF Ratio | 5.64 | 6.11 | 1.69 | 3.11 | - | - |
Net Debt / Equity Ratio | 0.58 | -0.04 | -0.02 | 0.30 | 0.44 | 0.21 |
Net Debt / EBITDA Ratio | -499.81 | -2.77 | -0.30 | 3.35 | 2.01 | 0.70 |
Net Debt / FCF Ratio | 3.40 | -0.48 | -0.09 | 1.89 | -3.62 | -3.05 |
Asset Turnover | 0.66 | 0.86 | 0.99 | 1.00 | 1.13 | 1.12 |
Quick Ratio | 3.90 | 3.69 | 3.83 | 3.37 | 2.96 | 3.27 |
Current Ratio | 4.01 | 3.72 | 4.02 | 3.61 | 3.25 | 3.44 |
Return on Equity (ROE) | -3.47% | -2.84% | 1.29% | 2.22% | 14.78% | 20.50% |
Return on Assets (ROA) | -2.24% | -2.08% | -0.02% | 1.11% | 6.99% | 10.39% |
Return on Invested Capital (ROIC) | -4.04% | -5.29% | -0.05% | 1.58% | 11.04% | 16.87% |
Return on Capital Employed (ROCE) | -3.50% | -3.90% | 0.00% | 2.10% | 12.20% | 19.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 |
Earnings Yield | -4.19% | -2.60% | 0.75% | 1.23% | 8.40% | 8.72% |
FCF Yield | 20.12% | 6.72% | 13.51% | 8.81% | -7.30% | -3.12% |
Dividend Yield | 1.51% | 1.11% | 0.69% | 0.67% | 1.47% | 1.61% |
Payout Ratio | - | - | 92.50% | 107.04% | 21.25% | 15.55% |
Buyback Yield / Dilution | - | - | - | 0.00% | -0.04% | -0.01% |
Total Shareholder Return | 1.51% | 1.11% | 0.69% | 0.67% | 1.43% | 1.60% |